Summit Therapeutics Inc. · Brief

Next report

2 days

Nov 3 · before openest.Q3 FY26

Expected move

±8.6%implied · straddle

14.6517.41

spot 16.03exp Nov 6ATM strike 16ATM straddle 1.62IV 92%

Oct 30 close

Expected move

—≥ implied

Q2 FY26—▼−8.81%—

quarterimplied−10%0+10%realized×

Q2 FY26—▼−8.81%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 3 report · est.

Bull2

23managers forming the concentrated core of reported holdings13F · Jun 30 '26

+2.41%largest reporting managers increasing combined shares over the latest quarter13F · Jun 30 '26

Bear2

9 of 20largest reporting managers that trimmed their position in the latest quarter13F · Jun 30 '26

244managers reporting a position in institutional filings13F · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

SMMT report session

No linked exposure.

Oct 20impliedImplied move: ±14.0% into Nov 3 earnings (Oct 20 close).Source

Oct 5impliedImplied move: ±13.1% into Oct 19 earnings (Oct 5 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.